Impact of Race and Genetic Factors on Beta Blocker Effectiveness in HF
Biomarkers (2)
- bp_sys - Systolic pressure (phv00334310.v1.p1)
- Creatinine_baseline_rslt - Creatinine result (phv00334315.v1.p1)
Demographics (2)
- age_at_enrollmt - Age in years at the time of enrollment (phv00334304.v1.p1)
- Sex - Sex (phv00334309.v1.p1)
Disease Events (1)
- cmrb_copd - Chronic Obstructive Pulmonary Disease (phv00334311.v1.p1)
Medications (3)
- ACE_use - ACE inhibitor use (phv00334312.v1.p1)
- ARB_use - Angiotensin II receptor blockers use (phv00334313.v1.p1)
- BB_use - Beta Blocker use (phv00334314.v1.p1)
Race and Ethnicity (2)
- ethnicity - Self-identified ethnicity (Hispanic vs. non-Hispanic) (phv00334306.v1.p1)
- Race - Self-identified race (phv00334305.v1.p1)
Other (13)
- analyte_type - The analyte type of sample (phv00334318.v1.p1)
- body_site - The body part from which the sample was collected (phv00334317.v1.p1)
- cma_exp_bb_mean - Mean beta blocker exposure metric (phv00334307.v1.p1)
- CONSENT - Consent group as determined by DAC (phv00334299.v1.p1)
- ech_ef - Ejection fraction (%) per echocardiogram (phv00334308.v1.p1)
- Histological_type - The type of sample, cell, or tissue type or subtype of the sample (phv00334319.v1.p1)
- is_tumor - The tumor status of the sample (phv00334320.v1.p1)
- SAMPLE_ID - Sample ID (phv00334316.v1.p1)
- SAMPLE_ID - Sample ID (phv00334301.v1.p1)
- SAMPLE_USE - Sample Use (phv00334302.v1.p1)
- SUBJECT_ID - De-identified sample ID (phv00334303.v1.p1)
- SUBJECT_ID - Subject ID (phv00334300.v1.p1)
- SUBJECT_ID - Subject ID (phv00334298.v1.p1)